RESUMO
The aim of present study was to enhance topical permeation of clotrimazole gel preparation by using various permeability enhancers such as coconut oil, pistachio oil and sodium lauryl sulphate (SLS). Clotrimazole gel preparations were prepared and optimized by using three factor, five level central composite design. A second-order polynomial equation was generated in order to estimate the effect of independent variables i.e. coconut oil (X1), pistachio oil (X2) and sodium lauryl sulphate (X3) at various dependent variables i.e. flux (Y1), lag time (Y2), diffusion coefficient (Y3), permeability coefficient (Y4), and input rate (Y5) of clotrimazole gel formulations. Ex vivo skin permeation study was performed through rat skin by using modified Franz diffusion cell system. Optimized formulation F8 exhibited highest flux 2.17 µg/cm2/min, permeability coefficient 0.0019 cm/min and input rate 1.543 µg/cm2/min, along with moderate lag time 77.27 min and diffusion coefficient 0.063 cm2/min, which is further supported by anti-fungal activity that exhibited more prominent zone of inhibition against Candida albicans, Aspergillus niger and Mucor. Thus, it can be concluded that permeation of clotrimazole gel was enhanced by various combination of coconut oil, pistachio oil and sodium lauryl sulphate but optimized formulation F8 containing 0.4 ml pistachio oil, 0.8 ml coconut oil and 0.04 g of SLS exhibited more pronounced and promising effect through rat skin.
Assuntos
Acrilatos , Clotrimazol/síntese química , Administração Tópica , Animais , Clotrimazol/administração & dosagem , Clotrimazol/farmacocinética , Óleo de Coco/farmacologia , Composição de Medicamentos/métodos , Géis , Técnicas In Vitro , Pistacia/química , Óleos de Plantas/farmacologia , Ratos , Absorção Cutânea , Dodecilsulfato de Sódio/farmacologiaRESUMO
Clotrimazole (CZ)-loaded microemulsion-containing nanofiber mats were developed as an alternative for oral candidiasis applications. The microemulsion was composed of oleic acid (O), Tween 80 (T80), and a co-surfactant such as benzyl alcohol (BzOH), ethyl alcohol (EtOH) or isopropyl alcohol (IPA). The nanofiber mats were obtained by electrospinning a blended solution of a CZ-loaded microemulsion and a mixed polymer solution of 2% (w/v) chitosan (CS) and 10% (w/v) polyvinyl alcohol (PVA) at a weight ratio of 30:70. The nanofiber mats were characterized using various analytical techniques. The entrapment efficiency, drug release, antifungal activity and cytotoxicity were investigated. The average diameter of the nanofiber mats was in the range of 105.91-125.56 nm. The differential scanning calorimetry (DSC) and powder X-ray diffractometry (PXRD) results revealed the amorphous state of the CZ-loaded microemulsions incorporated into the nanofiber mats. The entrapment efficiency of CZ in the mats was approximately 72.58-98.10%, depended on the microemulsion formulation. The release experiment demonstrated different CZ release characteristics from nanofiber mats prepared using different CZ-loaded microemulsions. The extent of drug release from the fiber mats at 4h was approximately 64.81-74.15%. The release kinetics appeared to follow Higuchi's model. In comparison with CZ lozenges (10mg), the nanofiber mats exhibited more rapid killing activity. Moreover, the nanofiber mats demonstrated desirable mucoadhesive properties and were safe for 2h. Therefore, the nanofiber mats have the potential to be promising candidates for oral candidiasis applications.
Assuntos
Antifúngicos/farmacologia , Candida albicans/efeitos dos fármacos , Clotrimazol/farmacologia , Nanofibras/química , Antifúngicos/síntese química , Antifúngicos/química , Linhagem Celular , Sobrevivência Celular/efeitos dos fármacos , Clotrimazol/síntese química , Clotrimazol/química , Relação Dose-Resposta a Droga , Emulsões/síntese química , Emulsões/química , Emulsões/farmacologia , Humanos , Testes de Sensibilidade Microbiana , Relação Estrutura-AtividadeRESUMO
Despite recent progress in the fight against malaria, the emergence and spread of drug-resistant parasites remains a serious obstacle to the treatment of infections. We recently reported the development of a novel antimalarial drug that combines the 4-aminoquinoline pharmacophore of chloroquine with that of clotrimazole-based antimalarials. Here we describe the optimization of this class of hybrid drug through in-depth structure-activity relationship studies. Antiplasmodial properties and mode of action were characterized in vitro and in vivo, and interactions with the parasite's 'chloroquine resistance transporter' were investigated in a Xenopus laevis oocyte expression system. These tests indicated that piperazine derivatives 4b and 4d may be suitable for coadministration with chloroquine against chloroquine-resistant parasites. The potential for metabolism of the drugs by cytochrome P450 was determined in silico, and the lead compounds were tested for toxicity and mutagenicity. A preliminary pharmacokinetic analysis undertaken in mice indicated that compound 4b has an optimal half-life.
Assuntos
Aminoquinolinas/síntese química , Antimaláricos/síntese química , Clotrimazol/análogos & derivados , Clotrimazol/síntese química , Aminoquinolinas/farmacocinética , Aminoquinolinas/farmacologia , Animais , Antimaláricos/farmacocinética , Antimaláricos/farmacologia , Transporte Biológico , Linhagem Celular , Cloroquina/farmacocinética , Cloroquina/farmacologia , Clotrimazol/farmacocinética , Clotrimazol/farmacologia , Resistência a Medicamentos , Feminino , Meia-Vida , Hemeproteínas/antagonistas & inibidores , Hemeproteínas/biossíntese , Humanos , Malária/tratamento farmacológico , Malária/parasitologia , Masculino , Proteínas de Membrana Transportadoras/genética , Proteínas de Membrana Transportadoras/fisiologia , Camundongos , Modelos Moleculares , Mutação , Oócitos/efeitos dos fármacos , Oócitos/metabolismo , Piperazinas/síntese química , Piperazinas/farmacocinética , Piperazinas/farmacologia , Plasmodium berghei , Plasmodium falciparum/efeitos dos fármacos , Proteínas de Protozoários/genética , Proteínas de Protozoários/fisiologia , Ratos , Ratos Sprague-Dawley , Estereoisomerismo , Relação Estrutura-Atividade , Pressão Ventricular/efeitos dos fármacos , Xenopus laevisRESUMO
We describe herein the design, synthesis, biological evaluation, and structure-activity relationship (SAR) studies of an innovative class of antimalarial agents based on a polyaromatic pharmacophore structurally related to clotrimazole and easy to synthesize by low-cost synthetic procedures. SAR studies delineated a number of structural features able to modulate the in vitro and in vivo antimalarial activity. A selected set of antimalarials was further biologically investigated and displayed low in vitro toxicity on a panel of human and murine cell lines. In vitro, the novel compounds proved to be selective for free heme, as demonstrated in the beta-hematin inhibitory activity assay, and did not show inhibitory activity against 14-alpha-lanosterol demethylase (a fungal P450 cytochrome). Compounds 2, 4e, and 4n exhibited in vivo activity against P. chabaudi after oral administration and thus represent promising antimalarial agents for further preclinical development.
Assuntos
Antimaláricos/síntese química , Clotrimazol/análogos & derivados , Clotrimazol/síntese química , Animais , Antifúngicos/síntese química , Antifúngicos/farmacologia , Antifúngicos/toxicidade , Antimaláricos/farmacologia , Antimaláricos/toxicidade , Linhagem Celular , Clotrimazol/farmacologia , Clotrimazol/toxicidade , Inibidores das Enzimas do Citocromo P-450 , Desenho de Fármacos , Feminino , Compostos Férricos/química , Heme/química , Humanos , Técnicas In Vitro , Camundongos , Modelos Moleculares , Oxirredutases/antagonistas & inibidores , Testes de Sensibilidade Parasitária , Plasmodium berghei/efeitos dos fármacos , Plasmodium chabaudi/efeitos dos fármacos , Plasmodium falciparum/efeitos dos fármacos , Protoporfirinas/química , Estereoisomerismo , Esterol 14-Desmetilase , Relação Estrutura-AtividadeRESUMO
Identification of new molecular scaffolds structurally unrelated to known antimalarials may represent a valid strategy to overcome resistance of P. falciparum (Pf) to currently available drugs. We describe herein the investigation of a new polycyclic pharmacophore, related to clotrimazole, to develop innovative antimalarial agents. This study allowed us to discover compounds characterized by a high in vitro potency, particularly against Pf CQ-resistant strains selectively targeting free heme, which are easy to synthesize by low-cost synthetic strategies.
Assuntos
Antimaláricos/síntese química , Clotrimazol/análogos & derivados , Clotrimazol/síntese química , Compostos Heterocíclicos de 4 ou mais Anéis/síntese química , Animais , Antifúngicos/síntese química , Antifúngicos/farmacologia , Antimaláricos/farmacologia , Linhagem Celular , Clotrimazol/farmacologia , Resistência a Medicamentos , Compostos Heterocíclicos de 4 ou mais Anéis/farmacologia , Humanos , Técnicas In Vitro , Modelos Moleculares , Plasmodium falciparum/efeitos dos fármacos , Relação Estrutura-AtividadeRESUMO
Clotrimazole (CT)-containing proliposomes were prepared by penetrating an ethanol solution of CT and Egg phosphatidylcholine (PC) into microporous sorbitol particles, followed by vacuum evaporation of the solvent. As a result, CT proliposomes with free-flowing flowability were obtained. On contact with water, the proliposomes were rapidly converted into a liposomal dispersion, in which a certain amount of CT was entrapped by the liposomes. The result in scanning electronic micrograph confirmed the formation of liposomes structures from proliposomes, and the particles revealed round or ellipse. The ratio of drug to total lipid, ratio of PC to cholesterol and ratio of lipid to sorbitol affected the entrapment efficiency (EE%). The EE% of optimized formulation (CT 10 mg, 0.1 g total lipid, PC/CH ratio is 60 : 40 and 1 g sorbitol) in this investigation was 96.2+/-1.5%. The proliposomes system can provide sustaining release in simulated vaginal fluid at 37+/-1 degrees C for 24 h. In-vivo performance of blank proliposomes, a physical mixture of sorbitol and drug, clotrimazole proliposomes and commercial ointment formulation were evaluated using antifungal activity test. At 7 d post-dose, the c.f.u. of C. albicans decreased in proliposomes-treated groups than ointment and the physical mixture (t-Student, p<0.05). The results indicated that CT-containing vaginal proliposomes prolonged drug release and may increase amount of drug retention into the mucosa to result in more antifungal efficacy. In addition, CT-proliposomes did not affect the morphology of vaginal tissues. Therefore, the dosage form might be further developed for safe, convenient, and effective treatment of vaginal candidasis with reduced dosing interval.
Assuntos
Clotrimazol/administração & dosagem , Clotrimazol/síntese química , Pró-Fármacos/administração & dosagem , Pró-Fármacos/síntese química , Animais , Clotrimazol/farmacocinética , Avaliação Pré-Clínica de Medicamentos/métodos , Feminino , Lipossomos , Pró-Fármacos/farmacocinética , Ratos , Ratos Sprague-Dawley , Vagina/citologia , Vagina/efeitos dos fármacosRESUMO
It was the purpose of this study to design and evaluate a new bioadhesive vaginal drug delivery system for clotrimazole. Chitosan, a cationic biopolymer derived by deacetylation of chitin, was modified by the introduction of thioglycolic acid (TGA). The modification was achieved by utilising a carbodiimide to link the carboxylic acid moieties of TGA covalently to the primary amino groups of chitosan. The amount of added carbodiimide was thereby varied, resulting in chitosan-TGA conjugates A and B with 160 microM (=micromol) and 280 microM thiol groups per gram polymer, respectively. In order to characterise the new polymers the water uptake, the disintegration behaviour, the bioadhesive properties utilising the rotating cylinder method, as well as the release of clotrimazole from tablets based on these derivatives were studied. The water uptake and cohesive properties of vaginal tablets consisting of these new conjugates could be significantly (p<0.05) improved. By adding clotrimazole the disintegration time of the conjugates was prolonged 1.6-fold for conjugate A and even 100-fold for conjugate B. Furthermore, the adhesion on vaginal mucosal tissue could be significantly improved. The addition of clotrimazole had also an impact on the adhesion time of chitosan-TGA conjugate B, which remained 26-times longer on vaginal mucosa than the corresponding unmodified polymer. The immobilisation of thiol groups guarantees a controlled drug release. Results of this study demonstrate that these new chitosan-TGA conjugates are very promising vehicles for the vaginal application of clotrimazole in treatment of mycotic infections.
Assuntos
Clotrimazol/administração & dosagem , Clotrimazol/química , Sistemas de Liberação de Medicamentos , Adesividade , Administração Intravaginal , Materiais Biocompatíveis/química , Quitina/análogos & derivados , Quitina/química , Quitosana , Clotrimazol/síntese química , Cinética , Compostos de Sulfidrila/síntese química , Compostos de Sulfidrila/química , ComprimidosAssuntos
Antifúngicos/síntese química , Clotrimazol/análogos & derivados , Imidazóis/síntese química , Antifúngicos/farmacologia , Fenômenos Químicos , Físico-Química , Clotrimazol/síntese química , Clotrimazol/farmacologia , Fungos/efeitos dos fármacos , Imidazóis/farmacologia , Testes de Sensibilidade MicrobianaRESUMO
1-Chloro-9-hydroxy-9-phenylxanthene reacts with imidazole at 180 degrees to form a 5:1 mixture of the 9-(imidazo-1-yl)- and 9-(imidazo-2-yl)-1-chloro-9-phenylxanthenes. These products lack significant antifungal activity.